You can buy or sell Nasdaq and other stocks, options, ETFs, and crypto commission-free!
Nasdaq, Inc. Common Stock, also called Nasdaq, is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information and public & private company services. Read More It operates through the following segments: Market Services, Corporate Services, Information Services and Market Technology. The Market Services segment includes its equity derivative trading and clearing, cash equity trading, FICC and trade management services businesses. The Corporate Services segment includes its corporate solutions and listing services businesses. The Information Services segment includes data products, index licensing and services businesses. The Market Technology segment is a global technology solutions provider and partner to exchanges, clearing organizations, central securities depositories, regulators, banks, brokers and corporate businesses. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Wall Street JournalMay 23
Nasdaq Chief Testifies in ETF Theft Lawsuit
Nasdaq Inc. Chief Executive Adena Friedman testified Thursday morning in the exchange’s lawsuit against a former business partner that Nasdaq contends stole more than $1 billion in exchange-traded funds. Nasdaq’s civil suit, filed in October 2017 in the U.S. District Court for the Southern District of New York, alleges that ETF Managers Group LLC improperly kept millions of dollars in management fees generated by funds including a popular cybersecurity ETF best known by its ticker HACK. ......
Wall Street JournalMay 23
NYSE Cuts Fees to Court Biotech Listings Away From Nasdaq
The New York Stock Exchange is making a bid to lure biotechnology IPOs that usually go to Nasdaq Inc., the latest sign of an intensifying rivalry between the two exchanges. NYSE is lowering fees for companies with little to no revenue, a typical characteristic of biotechnology firms still in the development phase. Biotechs historically have mostly listed on Nasdaq, in part because of its cheaper fees, more lenient listing standards and the prospect of inclusion in the popular Nasdaq Biotechnology Index. T...
Yahoo FinanceMay 21
It's Official: OrganiGram Is Approved for Nasdaq Listing
Having long been an industry that existed behind the scenes, the cannabis industry is maturing at an extraordinary rate. Between mid-2017 and mid-2018, pot companies spent most of their efforts on securing funding for capacity expansion, and actually constructing (or acquiring) cultivation farms and processing facilities. Now, marijuana companies have turned their attention to the next most important facet of their development: getting noticed! A television studio inside the Nasdaq Stock Exchange, complet...
Expected Jul 24, Pre-Market